| Source publication date | |
|---|---|
| Reported on Testosterone Science | |
| Outlet type | Mainstream news |
| Population | Men |
| Source | Irish Examiner |
| URL | irishexaminer.com/lifestyle/healthandwellbeing/arid-41808995.html (opens in a new tab) |
Specific Claim Evaluated
Studies find that about 30% of men aged 40 to 79 have clinically low testosterone.
Primary Research Supporting or Contradicting the Claim
In the European Male Ageing Study of men aged 40 to 79, late-onset hypogonadism defined by sexual symptoms and low testosterone affected 2.1% overall (Wu et al., 2010). In a US community cohort, symptomatic androgen deficiency affected 5.6% of men aged 30 to 79 (Araujo et al., 2007).
Corrected Evidence-Based Interpretation
A larger proportion of older men may have a single total testosterone value below a laboratory threshold, but clinically diagnosed hypogonadism affects roughly 2% to 6% of men aged 40 to 79.
Rationale for Grade
The article presents a biochemical prevalence as the prevalence of clinically low testosterone, overstating the clinical burden several-fold. Clinic-provided statements that prostate cancer concerns have been disproven are also reported without qualification.
References
- Araujo AB, Esche GR, Kupelian V, O'Donnell AB, Travison TG, Williams RE, Clark RV, McKinlay JB. Prevalence of symptomatic androgen deficiency in men. J Clin Endocrinol Metab. 2007;92(11):4241-4247. PMID
Supporting excerpt: "Crude prevalence of symptomatic androgen deficiency was 5.6%" - Wu FCW, Tajar A, Beynon JM, Pye SR, Silman AJ, Finn JD, O'Neill TW, Bartfai G, Casanueva FF, Forti G, et al. Identification of late-onset hypogonadism in middle-aged and elderly men. N Engl J Med. 2010;363(2):123-135. PMID
Supporting excerpt: "at least three sexual symptoms associated with a total testosterone level"